Q2 EPS Estimates for Teladoc Health Decreased by Analyst

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of Teladoc Health in a report issued on Wednesday, April 30th. Leerink Partnrs analyst M. Cherny now forecasts that the health services provider will post earnings per share of ($0.28) for the quarter, down from their previous estimate of ($0.22). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Leerink Partnrs also issued estimates for Teladoc Health's Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($0.97) EPS, FY2026 earnings at ($0.88) EPS and FY2027 earnings at ($0.69) EPS.

A number of other research firms have also issued reports on TDOC. Evercore ISI decreased their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research note on Thursday. Stifel Nicolaus decreased their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday. The Goldman Sachs Group decreased their target price on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday. Finally, Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $9.81.

Teladoc Health Stock Up 1.1 %

TDOC opened at $7.07 on Monday. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a market cap of $1.24 billion, a PE ratio of -1.23 and a beta of 1.82. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a 50 day moving average of $8.02 and a 200 day moving average of $9.49.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health in the 4th quarter worth about $29,000. Versant Capital Management Inc lifted its holdings in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Golden State Wealth Management LLC boosted its position in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares in the last quarter. Lindbrook Capital LLC grew its stake in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares during the last quarter. Finally, Sterling Capital Management LLC increased its position in Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.58% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.